Linked Life Data

10731277

Source:http://linkedlifedata.com/resource/pubmed/id/10731277

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-6-6
pubmed:abstractText
A 26-year-old man with severe dilated cardiomyopathy and frequent ventricular tachycardia treated with propafenone plus mexiletine underwent implantable cardioverter-defibrillator testing one day after dual chamber defibrillator implantation. There were no significant changes in the R-wave and lead position on chest x-ray. Routine defibrillator threshold (DFT) testing after 320 mg intravenous propofol demonstrated high DFTs (greater than 31 Joules and requiring 360 Joules externally for termination). Change in polarity failed to improve DFTs. After about 20 minutes of washout, conscious sedation was performed with 20 mg of midazolam and repeat DFTs were equal to 21 Joules. This case demonstrates the potential for an acute dose dependent rise in DFT with propofol.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1042-3931
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
121-3
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Elevation of defibrillation thresholds with propofol during implantable cardioverter-defibrillator testing.
pubmed:affiliation
Department of Medicine, WInthrop Univeersity Hospital, Mineola, NY 11501, USA. Tcohen@winthrop.org
pubmed:publicationType
Journal Article, Case Reports